Monoclonal Antibody Marstacimab Appears Safe and Effective in Patients With Severe Hemophilia
Researchers sought to determine whether marstacimab would be effective in treating patients with severe hemophilia.
Lauren Dembeck, PhD
Contributing Writer
Lauren Dembeck is a freelance science and medical writer and a contributing author for the Haymarket Medical Network. She holds a BS in biology and a BA in foreign languages from West Virginia University and a PhD in genetics from North Carolina State University. Prior to freelance writing, Lauren was a postdoctoral researcher at the Okinawa Institute of Science and Technology in Japan, where she studied developmental neurobiology. You can find more of her writing at https://laurendembeck.com/.
